Substance Use and Fitness
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01305902|
Recruitment Status : Completed
First Posted : March 1, 2011
Last Update Posted : June 18, 2012
|Condition or disease||Intervention/treatment||Phase|
|Substance Abuse Exercise||Behavioral: contingency management||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||45 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Substance Use and Fitness: A Pilot Study of Contingency Management in Older Adults|
|Study Start Date :||January 2011|
|Primary Completion Date :||April 2012|
|Study Completion Date :||April 2012|
No Intervention: walking recommendations
Participants assigned to this condition will be instructed to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. Each week, they will be congratulated if they walked the target goal on any days, and encouraged to meet the goals for the upcoming week. However, they will not receive any tangible reinforcement for walking. The meetings will be brief (about 15 minutes) and will include discussions and handouts related to the health benefits of walking.
Experimental: contingency management for walking
Participants assigned to this condition will be asked to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. The meeting duration and structure will be similar to that in the standard treatment condition including the handouts, with one exception. Participants in this condition will earn tangible reinforcement in the form of prizes for walking the target number of steps per day.
Behavioral: contingency management
Participants assigned to the experimental group will earn chances to win prizes if they have walked the recommended number of steps.
- number of days on which participants walked the recommended number of steps [ Time Frame: Weeks 1-12 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01305902
|United States, Connecticut|
|University of Connecticut Health Center|
|Farmington, Connecticut, United States, 06030|
|Principal Investigator:||Nancy M Petry, Ph.D.||University of Conncecticut Health Center|